Using tacrolimus in living donor liver transplantation recipients with high model for end-stage liver disease scores might increase the risk of postoperative neuropsychologic deficits

For decompensated liver cirrhosis and hepatocellular carcinoma, liver transplantation provides these patients the only curative treatment option with better long-term results. the model for end-stage liver disease (meld) system is a good tool to predict short-term mortality among these patients and has also been applied to allocate liver grafts to patients on waiting lists in several countries.